Category Archives: Science: Biology

Cutting edge research is happening on a daily basis in our modern world, Keep up to date with our Press Release services.

Weed Science Society of America Honors Award Winners at Annual Meeting


News Image

Yesterday the Weed Science Society of America (WSSA) honored more than two dozen individuals for their outstanding contributions to the field of weed science. The awards were presented during the organization’s annual meeting in Maui, Hawaii.

“This year’s honorees are making significant contributions to weed science through their research, teaching, publishing and outreach,” says Bill Curran, annual meeting program chair and incoming president of WSSA.

The 2020 winners include:

FELLOW AWARDS (WSSA’S HIGHEST RECOGNITION)

  •     Bryan G. Young, Ph.D., Purdue University
  •     Daniel B. Reynolds, Ph.D., Mississippi State University

HONORARY WSSA MEMBER

  •     Bhagirath Singh Chauhan, Ph.D., The University of Queensland (Australia)

OUTSTANDING EXTENSION AWARD

  •     John Byrd, Ph.D., Mississippi State University

OUTSTANDING RESEARCH AWARD

  •     Patrick J. Tranel, Ph.D., University of Illinois

OUTSTANDING TEACHER AWARD

  •     Baruch Rubin, Ph.D., The Hebrew University of Jerusalem

OUTSTANDING PAPER, INVASIVE PLANT SCIENCE AND MANAGEMENT


—    James Leary, Ph.D., University of Hawaii

—    Brooke Mahnken, Maui Invasive Species Committee

—    Christopher Wada, Ph.D., University of Hawaii

—    Kimberly Burnett, Ph.D., University of Hawaii

OUTSTANDING PAPER AWARD, WEED SCIENCE


—    Jacob S. Montgomery, University of Illinois

—    Ahmed Sadeque, University of Illinois

—    Darci A. Giacomini, Ph.D., University of Illinois

—    Patrick J. Brown, Ph.D., University of Illinois

—    Patrick J. Tranel, Ph.D., University of Illinois

OUTSTANDING PAPER AWARD, WEED TECHNOLOGY


—    Kathryn J. Lillie, University of Illinois

—    Darci A. Giacomini, Ph.D., University of Illinois

—    Patrick J. Tranel, Ph.D., University of Illinois

OUTSTANDING GRADUATE STUDENT AWARD

  •     Hudson Takano, Ph.D., Colorado State University

OUTSTANDING EARLY CAREER WEED SCIENTIST

  •     Muthukumar Bagavathiannan, Ph.D., Texas A&M University

OUTSTANDING INDUSTRY AWARD

  •     Terry R. Wright, Ph.D., Corteva Agriscience

OUTSTANDING REVIEWER AWARDS

  •     Vipan Kumar, Ph.D., Kansas State University (for Weed Science)
  •     Lauren Schwartz-Lazaro, Ph.D., Louisiana State University (for Weed Technology)
  •     Cynthia Huebner, Ph.D., USDA-USFS (for Invasive Plant Science and Management)

PUBLIC SERVICE AWARD

  •     Susan Koehler, Ph.D., USDA Animal and Plant Health Inspection Service

EXCELLENCE IN JOURNALISM AWARD

  •     Emily Unglesbee, DTN/The Progressive Farmer,

Biographical sketches of the winners are available in the 2020 annual meeting awards program, posted online on the WSSA website: http://wssa.net/wp-content/uploads/WSSA-2020-Awards-Program.pdf.

About the Weed Science Society of America

The Weed Science Society of America, a nonprofit scientific society, was founded in 1956 to encourage and promote the development of knowledge concerning weeds and their impact on the environment. The Society promotes research, education and extension outreach activities related to weeds, provides science-based information to the public and policy makers, fosters awareness of weeds and their impact on managed and natural ecosystems, and promotes cooperation among weed science organizations across the nation and around the world. For more information, visit http://www.wssa.net.

Share article on social media or email:

Evolution of Psychotherapy Announces “Father of Modern Linguistics” Noam Chomsky to Headline 35th Anniversary Conference


Evolution-Logo

We are honored to have such a revolutionary mind as Noam Chomsky contribute to our educational experience.

The Evolution of Psychotherapy Conference, the official meeting of the Milton H. Erickson Foundation, today announced that Noam Chomsky, “the father of modern linguistics,” will participate in a live video interview as part of the opening keynote session. The keynote will kick off the first day of the five-day meeting scheduled for December 9–13, 2020, in Anaheim, California.

An American theoretical linguist, Chomsky’s work revolutionized the field of linguistics by treating language as a uniquely human, biologically based cognitive capacity. His contributions to the field of cognitive psychology and the philosophies of mind and language helped initiate and sustain what became known as the “cognitive revolution.”

The interview-style session will be led by Dr. Jeffrey Zeig, director and founder of the Milton H. Erickson Foundation. Dr. Zeig will engage Chomsky in a discussion of how therapists can harness linguistics to become better communicators in order to improve patient relationships, understanding, and care.

“We are honored to have such a revolutionary mind as Noam Chomsky contribute to our educational experience,” said Dr. Zeig. “Noam has been the most-requested speaker for our conference for decades, and it is particularly special that he has chosen to join us for our 35-year anniversary meeting, which also coincides with the 135th anniversary of the practice of psychotherapy. This will truly be a once-in-a-lifetime experience for our attendees.”

Dubbed “the Woodstock of Psychotherapy” by TIME, the Evolution of Psychotherapy meeting is expected to attract 8,000 professionals from around the world who include clinical and counseling psychologists, psychiatrists, and marriage and family counselors. The meeting agenda is focused on strengthening clinical practice and highlighting the unifying principles that guide effective clinical work.

Participants in the 2020 meeting will gain insight from 50 expert faculty and 10 keynoters, each considered trailblazers in their field, and have the ability to earn up to 50 CE/CME credits.

To register for Evolution of Psychotherapy 2020 or to learn more, visit evolutionofpsychotherapy.com.

For press access and media inquiries, contact Kelly McCurdy at pr@hmpglobal.com.

About HMP

HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

About The Milton H. Erickson Foundation

Established in 1979, the Milton H. Erickson Foundation is a federal nonprofit corporation formed to promote and advance the contributions to the health sciences by the late Milton H. Erickson, MD. It has grown to become one of the most globally recognized and influential organizations in the field of psychotherapy and fulfills its mission through the organization of congresses, workshops, programs, and the development of clinically relevant content for mental health professionals. For more information, visit erickson-foundation.org.

Share article on social media or email:

GAP Solutions Awarded CDC’s Center for Preparedness and Response BPA


News Image

“GAP Solutions is proud to continue to support CDC and the CPR via a contract tailored to deliver preparedness, response, and recovery emergency support functions.” – Greg Bice

GAP Solutions, a leading provider of public health preparedness and response support to Health and Human Services (HHS) and the Federal Government, has been awarded a follow-on prime contract by the Centers for Disease Control and Prevention (CDC) Center for Preparedness and Response (CPR). The multiple-award Blanket Purchase Agreement (BPA) has a five-year base period of performance and a total potential value of $100 million. Additionally, on February 11th GAP Solutions was awarded the first Task Order released on the BPA, a 5-year order to provide support and assistance to CPR’s Division of Select Agents and Toxins (DSAT).

CPR leads CDC’s public health preparedness and response programs against broad range of potential threats including pandemics, natural disasters, and biological, chemical, nuclear, and/or radiological events. GAP Solutions is prepared to deliver rapid, flexible, and effective solutions to help CPR and its component divisions and offices deliver on their steady state and emergency response mission. Over the last decade, GAP Solutions has successfully performed related emergency preparedness and response requirements on behalf of CDC, the Assistant Secretary for Preparedness and Response (ASPR), HHS Supply Service Center (SSC), HHS Medical Reserve Corp (MRC), Food and Drug Administration (FDA), and National Institutes of Health (NIH).

“GAP Solutions is proud to continue to support CDC and the CPR via a contract tailored to deliver preparedness, response, and recovery emergency support functions,” said Greg Bice, GAP Solutions Vice President for Scientific and Technical Programs. “Our team is prepared to support 24/7 emergency response and recovery operations in response to public health emergencies or disaster events.”

About GAP Solutions

GAP Solutions has over 20 years of experience supporting our Customers unique mission requirements, including situational awareness, coordination, and planning activities and 24/7/365 emergency response operations following public health emergencies or disaster events. GAP Solutions leads and manages System One Federal Services, a unified delivery mechanism that leverages the diverse, scalable, and innovative capabilities of System One into a single, unified solution for our partners at HHS, DHS, and the DoD. With access to over 450 specialized recruiters, GAP Solutions in uniquely prepared to support our Customer missions as science, technology, engineering, and medicine continue to evolve.

Share article on social media or email:

Jain Irrigation Announces Launch of Jain Unity® for Water Management


Aric Olson, President of Jain Irrigation, said, “Jain Unity builds upon the patented core ETwater technology we acquired in 2018 to now offer a wealth of environmental services along with the renown, centralized smart irrigation control.”

Jain Irrigation makes history with first-ever irrigation automation to use AI and predictive analytics.


  • Unity answers the question, “How much water does a landscape need?”
  • Unity decides when and how much an irrigation system needs to operate, allowing for as much available rainfall or precipitation as possible before initiating a watering schedule saving users water and establishing a more beautiful landscape.
  • Unity is an environmental data platform offering an Evapotranspiration (ET) and other environmental calculations derived from multi-sources for companies to build their own products.
  • Unity connects over secure cellular wireless to all models of existing ETwater smart controllers and other units in the field.


Jain Irrigation, Inc., (“JAIN”), the world leader in irrigation technology, today announces the general availability (GA) release of JAIN Unity, an automatic irrigation control system and environmental data services platform. Unity is the first-ever smart irrigation solution for landscape management fully powered by artificial intelligence and predictive analytics.

Jain Unity gives users (contractors, water managers, home and building owners) direct access to view how much water the plants in their landscape requires, along with real-time visibility to the efficiency of their irrigation system for eliminating water waste.

Arcadis and Bluefield Research recently released a report that is projecting over 36% of U.S. households won’t be able to afford water in the next five years. “Irrigation, like landscaping in general, is fertile ground for AI to be a game-changer in sustaining our water supply,” said Richard Restuccia, VP Water Management Solutions at JAIN.

“Jain Unity processes over a billion pieces of information hourly on how soil moisture responds to rain or irrigation events based on the different plant factors, soil types, weather, and environmental conditions at the site-specific location. Connecting to irrigation control that automatically acts upon this algorithm to implement the best strategies for minimizing water usage, and managing nutrient loss fulfills the promise of AI and predictive analytics. A user’s ability to see and understand their water usage outdoors engages them directly in its conservation; reinforcing changes to their behavior that can add up to substantial cost savings for them, while also contributing to greater water resource savings for our communities’ livability and affordability.”

Aric Olson, President of Jain Irrigation, said, “Jain Unity builds upon the patented core ETwater technology we acquired in 2018 to now offer a wealth of environmental services along with the renown, centralized smart irrigation control. Designed for extensibility that allows swift integration of virtually an unlimited number of data sources, the Unity platform can cross-correlate and analyze data in a learning system that intelligently, automatically adapts to make continuous improvement for sustainable resource consumption. Its release marks an important event for JAIN toward ‘unifying’ our broad AgTech base worldwide and meeting the challenges in a rapidly changing future of water.”

About Jain Irrigation, Inc.

Jain is a fully integrated global food/plant production company recognized by Harvard Business to be one of five global sustainability champions and the G-20 for lifting people out of poverty. Our irrigation manufacturing capabilities include everything from behind the pump to the flush valve at the end of the lateral and everything in between, including drip irrigation. We lead the industry in manufacturing technology, owning both our extrusion and mold manufacturing equipment providers. Jain leads plant science research globally across a variety of food crops and is staffed with some of the world’s leading research scientists. With the Gandhi Library, Jain now houses the leading collection of the world’s best plant science knowledge in a single facility. Our agronomic knowledge is integrated from our world-class tissue culture operations through our food processing businesses. We research, educate, advance, manufacture, finance, propagate plants, and purchase produce for processing all to fulfill the Jain mission, “leave this world better than you found it.”

http://www.jainsusa.com

Share article on social media or email:

Rigaku Presents Latest Analytical Instruments at Pittcon Conference and Expo


Rigaku MiniFlex XRD

Rigaku MiniFlex benchtop X-ray diffraction (XRD) instrument

Rigaku is exhibiting its benchtop lines of X-ray diffraction (XRD), X-ray fluorescence (XRF), as well as handheld Raman and laser induced breakdown spectroscopy (LIBS) instrumentation at Booth # 4725.

Rigaku Corporation is pleased to announce its attendance at the 71st annual Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon 2020), being held March 1 – 5, at McCormick Place in Chicago, Illinois. Pittcon is the world’s leading annual conference and exposition on laboratory science, attracting attendees from industry, academia and government from over 90 countries worldwide. Rigaku is exhibiting its benchtop lines of X-ray diffraction (XRD), X-ray fluorescence (XRF), as well as handheld Raman and laser induced breakdown spectroscopy (LIBS) instrumentation at Booth # 4725.

Rigaku (The Woodlands, TX) is showing the Rigaku MiniFlex benchtop X-ray diffractometer, and the Rigaku Supermini200 benchtop wavelength dispersive X-ray fluorescence (WDXRF) spectrometer.

Ideally suited for today’s fast-paced XRD analyses, the sixth generation MiniFlex system delivers speed and sensitivity through innovative technology enhancements such as the optional D/teX high-speed detector coupled with a powerful 600 W X-ray source. The MiniFlex comes standard with the latest version of PDXL, Rigaku’s full-function powder diffraction analysis package.

The Supermini200 analyzer is the world’s only high-power (200 W) benchtop sequential wavelength dispersive X-ray fluorescence spectrometer for elemental analysis of oxygen (O) through uranium (U) of almost any material. It uniquely delivers low cost-of-ownership with high resolution and lower limits of detection (LLD).

Applied Rigaku Technologies, Inc. (ART, Austin, TX) is presenting the Rigaku NEX QC series of low-cost benchtop EDXRF spectrometers. The NEX QC and NEX QC+ systems are compact elemental analyzers with intuitive “icon-driven” touch screens interface and built-in printer for easy operation and convenience. The series also includes the Rigaku NEX QC+ QuantEZ analyzer, engineered for heavy industrial use, which runs on Microsoft Windows-based QuantEZ analytical software.

The Rigaku NEX DE series of high-performance, direct excitation EDXRF elemental analyzers is also featured. On display is the Rigaku NEX DE VS direct excitation variable spot X-ray fluorescence elemental analyzer. The NEX DE VS system is uniquely suited for small spot analysis. It features a high-resolution camera combined with automated collimators allowing for precise positioning of a sample for the analysis of 1 mm, 3 mm, and 10 mm spot sizes.

Handheld and portable spectrometers from Rigaku Analytical Devices (RAD, Wilmington, MA) are also displayed at the Rigaku booth. RAD is featuring their latest Raman and LIBS analyzers, including the Rigaku Progeny and Rigaku Progeny ResQ 1064nm handheld Raman analyzers, as well as the new Rigaku ResQ CQL 1064 nm handheld Raman analyzer for explosives & narcotics detection. The Rigaku KT-100S handheld LIBS spectrometer for fast, precise alloy identification is also featured.

RAD will also present a talk entitled, “Library and Method Development – what Lies Behind the Black Box?” hosted by Dr. Suzanne Schreyer, Sr. Applications Scientist on March 3 from 3:35 – 4:10pm in Room 181B.

About Rigaku

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, diffraction, and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,400 people in the manufacturing and support of its analytical equipment, which is used in more than 90 countries around the world supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.

For further information, contact:

Michael Nelson

Rigaku Global Marketing Group

tel: +1. 512-225-1796

michael.nelson@rigaku.com

Share article on social media or email:

Panitch Schwarze Adds Biotechnology and Life Science Experts to IP team


News Image

Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce that Travis W. Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany G. Small, Ph.D., has joined the firm as a patent agent.

Bliss is an experienced patent attorney and will be a partner in the firm’s biotechnology and life science practice group. He has significant experience with domestic and foreign patent applications and trademark procurement. His practice also involves IP counseling, providing a comprehensive view of the IP landscape to help clients to determine strategy. His experience in life sciences includes assisting companies in the biotechnology and pharmaceutical industries, as well in the agriculture, horticulture, cannabis, and hemp industries. Bliss is a thought leader in the area of procuring and monetizing IP protections for plant-based inventions, including novel cannabis and hemp varieties and products. He also is ranked in the Nationwide Band 1 for cannabis law by Chambers USA.

Bliss’s IP litigation experience includes litigating patent and trademark infringement disputes, trade secret disputes, licensing disputes and inventorship disputes in both state and federal courts. He has defended both large and small companies against charges of trade secret misappropriation and patent infringement. Bliss has litigated numerous disputes, including patent interference and inter partes review proceedings, before the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB).

Bliss earned his bachelor’s degree in animal science with a concentration in agricultural biotechnology and his doctoral degree in animal science focusing on molecular genetics, immunology, and biotechnology from the University of Delaware. He received his law degree, summa cum laude, from Widener University. Prior to joining Panitch Schwarze, he served as chair of the IP Biotechnology & Life Sciences practice group at Buchanan Ingersoll & Rooney P.C.

Small is an experienced patent agent with expertise in life science fields. As a new member of the firm’s life sciences practice group, Small provides technical support and scientific expertise in the pharmaceutical and biotechnical arts, as well as in the area of IP protections for novel plant varieties. She assists clients in the preparation, filing and prosecution of domestic and foreign patent applications, as well as conducting searches and reviews for due diligence, patentability and freedom to operate analyses. She is involved in FDA Orange Book submissions and Patent Term Extension Applications, and has also litigated patent interferences and inter partes review proceedings before the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB).

Small earned a bachelor’s degree in biology and theology from The Franciscan University of Steubenville and her doctoral degree in cellular and microbial biology from The Catholic University of America, where she was recognized with the Roland M. Nardone Award for Excellence in Teaching Assistance. Prior to joining Panitch Schwarze, Small worked as a patent agent at another law firm in the Philadelphia area.

“We are pleased to welcome Travis and Stephany to our life sciences team,” said managing partner Martin Belisario “Their experience in sciences, including novel plant varieties, complements our team members’ experience and skills to expand the firm’s ability to support our clients’ growing needs in the pharmaceutical and biotechnology arena.”

To learn more, visit the firm’s website.

About Panitch Schwarze Belisario & Nadel LLP – Panitch Schwarze Belisario & Nadel LLP is a boutique intellectual property law firm with offices in Philadelphia and Wilmington, Delaware. The firm’s IP law practitioners provide strategic litigation, licensing and counseling service relating to patents, trademarks, copyrights and trade secrets, domain names and internet issues domestically and internationally. The firm’s long-standing relationships with a network of associates worldwide enable its attorneys and advisors to provide clients with global intellectual property advice and protection.

Share article on social media or email:

University Epidemiologist Talks Coronavirus and Contingency Plans


Dr. Elizabeth Rcaz, an epidemiologist at South Dakota Mines, lectures to a biology class on virology this week. The image she is holding is COVID-19 or coronavirus.

Don’t panic, but be prepared.

In the wake of the Centers for Disease Control and Preventions’ recent warnings on the spread of the COVID-19 (known as coronavirus), South Dakota School of Mines & Technology lecturer and epidemiologist Elizabeth Racz, Ph.D., MPH, advises people to be cautious and use common sense.

“Don’t panic, but be prepared,” Racz says. “Protect yourself by sleeping well, eating well, keeping your immune system in good shape.” In addition, think about your “community” in case of a quarantine or illness, and consider what you would need, she says, “Who will you help and who will help you? What resources will you need?”

As of Feb. 27, there were 82,294 reported cases of coronavirus worldwide, according to the World Health Organization (WHO) and 62 in the United States, according to the CDC. The South Dakota Department of Health currently shows zero cases in the state.

The coronavirus was first detected in Wuhan City in China in January and has spread around the world in a relatively short period. Like the viruses SARS-CoV and MERS-CoV, coronavirus spread from animals to humans, although the definitive animal source has yet to be identified, Racz says. The “spillover” of the virus was likely due to human consumption of an animal or proximity to the animal, Racz says. The virus is now spreading from human to human, according to the CDC. Racz says in most cases of animal to human spread, the viruses don’t become contagious between humans as quickly as coronavirus did. This is just one of the “unique” things about this virus, she says. The current death rate from the coronavirus is approximately 2% with the highest death rate for people – particularly men – older than 60. Symptoms of the virus include fever, cough and shortness of breath.

Like many universities, South Dakota Mines has been monitoring the coronavirus situation since it first surfaced, adding i nformation and resources on its website for students in January, according to South Dakota Mines President Jim Rankin.

The university has an emergency management plan and an emergency management team that meets and trains regularly to address situations such as a virus outbreak. In the event of a contagious disease outbreak on campus, the university would follow the recommendations of the CDC, the State Epidemiologist, the SD Dept of Health, healthcare providers on campus and other health officials, Rankin says. “We would be working closely with emergency management officials in local, state, and federal offices to ensure the safety of our students, faculty and staff,” he says.

The South Dakota Board of Regents is also keeping a close eye on the outbreak, releasing a statement that reads, “Our campuses monitor these types of situations closely and they have processes/procedures in place to assess and address any impact on operations resulting therefrom. At present, our campuses are continuing to follow their normal processes for monitoring and addressing issues such as this, and no special system action has been taken with respect to the Coronavirus specifically.”

Racz, who teaches in the chemistry, biology and health sciences department, said one complication in this outbreak is that many people who become infected could be asymptomatic, but still infectious. For that reason, common sense measures are needed to prevent a spread. These include:

  • Wash hands regularly and properly
  • Do not touch your face, including your eyes
  • Cover cough with arm or cloth
  • Stay home when sick. Racz points out that employers have a responsibility to their employees to encourage them to take sick time without fear of job loss.
  • Keep surfaces, light switches, doorknobs clean
  • Maintain good sleep hygiene
  • Eat healthy
  • Reduce stress


Racz says much is not known about this virus because it’s completely new to humans. “Our bodies have never seen this before,” she says. “Our bodies are naïve to this virus.” According to the CDC, it could be more than a year before a vaccine can be developed to combat the coronavirus.

In the meantime, Racz urges people to obtain their information about the virus from reputable sources such as the CDC and the World Health Organization.

Share article on social media or email:

Regen Suppliers Now Offering 20% Discount On Biologics Orders to New Customers


stem cell and Exosome supplier

Offering 20% Discount on First Time Biologics Orders for Stem Cells and Exosomes

The response from regenerative practices nationwide has been incredible! Having such a vast assortment of first rate regenerative products in one place makes it super easy and convenient to satisfy practice needs without the hassle!

Regen Suppliers is now offering first time customers a 20% discount on initial biologics orders. This includes all available stem cell and exosome biologics.

Regen Suppliers offers an extensive variety of regenerative therapy products, including amniotic and umbilical tissue, Exosome Biologics, PRP kits, adipose kits, PDO thread lifts and more. The company is truly a one stop shop for regenerative products. According to VP Kathleen Francesca, “The response from regenerative practices nationwide has been incredible! Having such a vast assortment of first rate regenerative products in one place makes it super easy and convenient to satisfy practice needs without the hassle!”

There are numerous options available for amniotic and umbilical cord tissue biologics. This includes several sizes, cell counts and price points. For example, Regen Suppliers has its own line for umbilical cord tissue and Exosome Biologics. These are ReBella and ReBellaXO, which are very high quality and cost effective for providers at medical practices, Med Spas and all types of regenerative clinics. As an umbilical cord stem cell supplier, Regen Suppliers takes safety as a paramount concern.

In addition to regenerative biologics, Regen Suppliers also offers top notch PRP centrifuges and kits, cryogenic freezers, PDO thread lift products, microneedling devices, intranasal catheters, and multivitamin IV kits too. The excellent one stop shop website allows healthcare providers and practices to only have to work with one supplier for their regenerative products. In addition, Regen Suppliers has also teamed up with R3 Medical Training for provider’s regenerative medicine training courses.

The 20% discount is available to all initial biologics orders from qualifying medical providers. Simply call (888) 568-6909 or visit the website at https://regensuppliers.com to make an inquiry.

Share article on social media or email:

Kureha Invests in US Startup Boost Biomes


Kureha Corporation announced today that it has made a seed investment in California, US-based Boost Biomes Inc., via its wholly-owned subsidiary Kureha America Inc.

Boost Biomes is an early-stage startup, which develops microbial products. The company has a microbiome discovery platform, a proprietary technology exclusively licensed by the Lawrence Berkeley National Laboratory. Their unique platform technology enables the company to identify interactions among members of a microbiome and quickly screen combinations of different microbes that yield desired effects suitable for use in various fields such as bio-fungicides and food preservatives.

With this investment in Boost Biomes, Kureha will leverage their innovative technology to address social issues and to contribute to human’s healthier lifestyles, with the aim of expanding its business portfolio.

Under the mid-term management plan ‘Kureha’s Challenge 2020’, Kureha is actively exploring business opportunities in Japan and globally and accelerating business development with external resources. As a part of this initiative, Boost Biomes represents the first seed-stage investment.

“Kureha is seeking new opportunities for joint development with or investment in early-stage startups with strong strategic fit to us in its value proposition. Through this open innovation activity, we will keep working to generate a number of potential new business seeds. This strategic partnership with Boost Biomes can accelerate creating innovative products,” said Naomitsu Nishihata, President of Kureha America.

Boost Biomes’ CEO, Jamie Bacher, said, “This investment from Kureha emphasizes that Boost has now demonstrated the path from discovery to commercial opportunity. Our proprietary technology platform enables our global commercial and co-development partners opportunities to generate novel, highly-effective microbial products that are natural, organic and safe.”

About Boost Biomes Inc.

Boost Biomes is developing new products to address critical needs in agriculture, to increase crop yields and reduce post-harvest waste. Underlying the products is a proprietary microbiome technology platform that enables Boost a unique understanding of interactions within microbiomes, leading to superior products that are effective, safe, organic and natural. For more information, visit http://boostbiomes.com/

*Details of Kureha’s investment in Boost Biomes are not disclosed.

About Kureha Corporation:

Kureha Corporation is a manufacturer of highly original specialty chemicals and plastics that leverages proprietary technologies to develop products in the fields of advanced materials, agrochemicals, pharmaceuticals, and packaging materials. Since its establishment in 1944, Kureha has utilized its strengths in technology and innovation to provide a wide range of solutions suited to the market needs of each era. For more information, visit https://www.kureha.co.jp/en/

For inquiries about this news release, please contact Kureha America Inc.

Tel: 1-281-916-1633

Share article on social media or email:

G-CON PODs® Selected as Supplier for Clinical and Commercial Manufacturing Facility in Redmond, Washington


We treasure the partnership with Just – Evotec Biologics, a company supporting the shared vision of highly flexible and readily deployable manufacturing sites.

G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions announced today that the company will support Just – Evotec Biologics, a wholly-owned Seattle-based company of Evotec SE, with their construction of a late-stage clinical and commercial manufacturing facility for biologics in Redmond, Washington. The news comes shortly after the announcement of the construction of Just – Evotec Biologics’ first J.POD® facility in North America, creating the “Facility of the Future” to provide flexible and modular, larger scale manufacturing of clinical and commercial-stage biologics.

Just – Evotec Biologics’ J.POD® technology features small intensified bioprocessing operations housed inside G-CON cleanroom PODs. G-CON will design and fabricate the PODs for cGMP manufacturing suites that require mobility and reconfigurability to meet current and future needs. The one-of-a-kind cGMP biomanufacturing facility includes six J.PODs® for upstream and downstream processing, totaling 8,825 sq. ft. of cleanroom space using the G-CON POD product. A key feature of the facility is its flexible platform design with the ability to scale out with additional PODs in the future without interrupting existing processes, resulting in zero operational scale-up risks.

The facility is part of Just – Evotec Biologics’ plan to provide flexible, high-quality manufacturing while de-risking drug discovery and development, not only for Just – Evotec Biologics, but also for Evotec’s partners.

“We treasure the partnership with Just – Evotec Biologics, a company supporting the shared vision of highly flexible and readily deployable manufacturing sites,” stated Maik Jornitz, CEO of G-CON.

About G-CON Manufacturing

G-CON Manufacturing designs, builds and installs prefabricated G-CON POD® cleanrooms. G-CON’s POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD® cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON’s website at http://www.gconbio.com. Follow us on Twitter at @g_con_pods.

About Just – Evotec Biologics

Just – Evotec Biologics wholly owned by Evotec SE is a unique platform company that integrates the design, engineering, development, and manufacture of biologics. With deep experience in the fields of protein, process and manufacturing sciences, the Just team came together to solve the scientific and technical hurdles that block access to life-changing protein therapeutics; from the design of therapeutic molecules to the design of the manufacturing plants used to produce them. Our focus is to create access and value for a global market through scientific and technological innovation. Learn more at http://www.just.bio.

About Evotec SE

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,900 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry’s need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, fibrosis, rare diseases and women’s health. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others. For additional information please go to http://www.evotec.com and follow us on Twitter @Evotec.

Share article on social media or email: